TGY2IT
IART icon

Timothy G. Youngquist 2020 Irrevocable Trust’s Integra LifeSciences IART Stock Holding History

Timothy G. Youngquist 2020 Irrevocable Trust’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,264
Closed -$21.3K – 293
2026
Q1 		$21.3K Buy
+2,264
New +$24.9K 0.01% 310

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $391M AUM 21.6% 1-Year Est. Return
LI
Leeward Investments Boston, Massachusetts $2.2B AUM 46.08% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Timothy G. Youngquist 2020 Irrevocable Trust's IART Position: Q2 2026 in Review

Timothy G. Youngquist 2020 Irrevocable Trust sold out of Integra LifeSciences (IART) in Q2 2026, closing a stake of 2,264 shares — an estimated $21.3K sold.

Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in IART in Q1 2026 and held it in 1 quarter. The position peaked at $21.3K in Q1 2026. 78 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Timothy G. Youngquist 2020 Irrevocable Trust reported no remaining Integra LifeSciences position as of Q2 2026 after selling out during the quarter.
  • Timothy G. Youngquist 2020 Irrevocable Trust sold 2,264 Integra LifeSciences shares in Q2 2026, an estimated $21.3K.
  • Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in Integra LifeSciences in Q1 2026 and held it in 1 quarter.
  • Timothy G. Youngquist 2020 Irrevocable Trust's Integra LifeSciences position peaked at $21.3K in Q1 2026.
  • 78 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Timothy G. Youngquist 2020 Irrevocable Trust's 13F filing for Q2 2026, filed 7 Aug 2026.